13F Holdings
中文EN

NEO NEOGENOMICS INC

Services-Testing Laboratories · Nasdaq · SEC CIK 1077183 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.1%
TTM net income YoY71.5%
TTM EPS YoY71.6%
Revenue 3-yr CAGR11.1%
Net income 3-yr CAGR—

Margins

Gross margin44.8%
Operating margin-6.3%
Net margin-4.1%
FCF margin-3.6%
EBITDA margin-1.9%

Returns

ROE-3.9%
ROA-2.3%
ROIC (approx.)-4.6%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets41.9%
Debt / equity0.47x
Current ratio3.53x
Interest coverage-15.21x

Cash quality & payout

Operating cash flow / net income-0.13x
Accruals ratio-2.7%
Payout ratio—
Capex / revenue4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$727.33M$660.57M$591.64M$509.73M$484.33M
Cost of revenue$413.04M$370.47M$347.04M$321.83M$297.27M
Gross profit$314.29M$290.10M$244.60M$187.90M$187.06M
R&D expense$37.08M$31.16M$27.31M$30.33M$21.87M
SG&A expense$273.34M$259.74M$243.10M$243.36M$221.35M
Operating income-$115.88M-$92.11M-$107.74M-$157.62M-$118.75M
Interest expense$3.75M$6.62M$6.91M$7.58M$8.22M
Pretax income-$110.27M-$80.67M-$97.10M-$159.34M-$15.07M
Income tax-$2.24M-$1.95M-$9.13M-$15.09M-$6.73M
Net income-$108.03M-$78.73M-$87.97M-$144.25M-$8.35M
EBITDA-$79.81M-$53.01M-$70.29M-$122.25M-$88.56M
EPS (diluted)—————
Weighted avg. shares (diluted)128.10M126.66M125.50M124.22M119.96M
Balance sheet
Cash & equivalents$159.62M$367.01M$342.49M$263.18M$316.83M
Short-term investments————$198.56M
Receivables$159.24M$150.54M$131.23M$119.71M$112.13M
Inventory$28.57M$26.75M$24.16M$24.28M$23.39M
Current assets$376.29M$596.02M$596.81M$605.29M$681.51M
PP&E, net$84.83M$94.10M$92.01M$102.50M$109.47M
Goodwill$524.34M$522.77M$522.77M$522.77M$527.12M
Intangibles$286.53M$339.68M$373.13M$408.26M$442.32M
Total assets$1.36B$1.64B$1.68B$1.74B$1.87B
Current liabilities$88.30M$301.24M$96.30M$89.93M$87.23M
Short-term debt$0$200.78M$0$70,000$1.14M
Long-term debt$341.86M$340.33M$538.20M$535.32M$532.55M
Total debt$341.86M$541.11M$538.20M$535.39M$533.69M
Total liabilities$523.27M$735.70M$739.69M$742.01M$761.50M
Shareholders' equity$836.56M$902.34M$941.54M$998.02M$1.11B
Net debt$182.24M$174.10M$195.71M$272.21M$216.86M
Shares outstanding128.99M128.15M127.37M126.91M124.11M
Cash flow statement
Operating cash flow$5.23M$7.02M-$1.95M-$65.99M-$26.72M
Capital expenditure$27.01M$41.06M$28.75M$30.89M$64.14M
Free cash flow-$21.78M-$34.04M-$30.70M-$96.88M-$90.86M
Investing cash flow-$12.34M$12.86M$76.71M$517,000-$632.37M
Financing cash flow-$200.29M$4.65M$4.55M$11.83M$725.28M
Depreciation & amortization$36.07M$39.10M$37.45M$35.37M$30.19M
Stock-based compensation$41.32M$33.41M$24.63M$24.67M$22.46M

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.